222 related articles for article (PubMed ID: 4714835)
1. Ergotamine and methysergide abuse in patients with migraine.
Lucas RN; Falkowski W
Br J Psychiatry; 1973 Feb; 122(567):199-203. PubMed ID: 4714835
[No Abstract] [Full Text] [Related]
2. [Ergotamine addiction in migraine patients].
Retterstol N
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2122. PubMed ID: 4773989
[No Abstract] [Full Text] [Related]
3. Atypical migraine.
Patten JP
Practitioner; 1973 Sep; 211(263):304-9. PubMed ID: 4759237
[No Abstract] [Full Text] [Related]
4. Ergotamine and methysergide as serotonin partial agonists in migraine.
Fanciullacci M; Granchi G; Sicuteri F
Headache; 1976 Nov; 16(5):226-31. PubMed ID: 977328
[No Abstract] [Full Text] [Related]
5. [Treatment of migraine].
Girard M
J Med Lyon; 1969 Dec; 50(177):1777-89. PubMed ID: 5374235
[No Abstract] [Full Text] [Related]
6. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
Dahlöf C; Maassen Van Den Brink A
Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
[TBL] [Abstract][Full Text] [Related]
7. Treatment of migraine headache.
Bianchine JR; Speed WG
Johns Hopkins Med J; 1968 Jul; 123(1):38-40. PubMed ID: 5667657
[No Abstract] [Full Text] [Related]
8. Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives.
Barrie MA; Fox WR; Weatherall M; Wilkinson MI
Q J Med; 1968 Apr; 37(146):319-36. PubMed ID: 4873708
[No Abstract] [Full Text] [Related]
9. [Progress in the treatment of migraine and migrainoid headaches].
Kaemmerer E
Med Welt; 1966 Dec; 51():2812-4. PubMed ID: 5976170
[No Abstract] [Full Text] [Related]
10. [Clinical considerations on the pathogenesis of intermittent and paroxysmal headache].
Tzetzu I; Arteni V; Chivu V
Ann Otolaryngol Chir Cervicofac; 1967; 84(4):335-8. PubMed ID: 6073410
[No Abstract] [Full Text] [Related]
11. Studies in migraine.
Lance JW
Proc Aust Assoc Neurol; 1966; 4():81-4. PubMed ID: 5966206
[No Abstract] [Full Text] [Related]
12. Ergotamine abuse. Do patients benefit from withdrawal?
Tfelt-Hansen P; Krabbe A
Cephalalgia; 1981 Mar; 1(1):29-32. PubMed ID: 15645831
[TBL] [Abstract][Full Text] [Related]
13. Effects of ergotamine and methysergide on blood platelet aggregation responses of migrainous subjects.
Hilton BP; Zilkha KJ
J Neurol Neurosurg Psychiatry; 1974 May; 37(5):593-7. PubMed ID: 4836755
[TBL] [Abstract][Full Text] [Related]
14. A critical review of the treatment of migrainous neuralgia.
Mann P; Sutherland JM; Eadie MJ
Proc Aust Assoc Neurol; 1970; 7():49-53. PubMed ID: 5514825
[No Abstract] [Full Text] [Related]
15. Migraine.
Elithorn A
Br Med J; 1969 Nov; 4(5680):411-3. PubMed ID: 5354814
[No Abstract] [Full Text] [Related]
16. [Progress of clinical pharmacology in essential headaches].
Fanciullacci M; Franchi G; Galli P
Minerva Med; 1976 Jun; 67(28):1834-9. PubMed ID: 1084498
[TBL] [Abstract][Full Text] [Related]
17. Migraine headaches.
Friedman AP
JAMA; 1972 Dec; 222(11):1399-402. PubMed ID: 4678317
[No Abstract] [Full Text] [Related]
18. The management of migraine.
Eadie MJ
Med J Aust; 1975 Jun; 1(24):752-4. PubMed ID: 239308
[No Abstract] [Full Text] [Related]
19. Rational treatment of migraine.
Weber RB
South Med J; 1972 Jun; 65(6):737-40. PubMed ID: 5032378
[No Abstract] [Full Text] [Related]
20. Gangrene induced by methysergide and ergotamine. A case report.
Vaughan-Lane T
J Bone Joint Surg Br; 1979 May; 61-B(2):213-4. PubMed ID: 438273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
